Semax
Advanced nootropic peptide for cognitive enhancement and neuroprotection research. ACTH-derived heptapeptide with potent BDNF modulation capabilities.
Semax is a synthetic heptapeptide derived from the 4-10 amino acid fragment of Adrenocorticotropic Hormone (ACTH) (Met-Glu-His-Phe-Pro-Gly-Pro). Through structural optimization, Semax significantly enhances neuroprotective, cognitive-enhancing, and neuromodulatory activities while eliminating the hormonal side effects of native ACTH. By modulating Brain-Derived Neurotrophic Factor (BDNF) expression, optimizing brain monoamine neurotransmitter levels, and promoting cerebral cortical blood perfusion, Semax demonstrates broad application prospects in improving focus, enhancing memory consolidation and retrieval, and accelerating cognitive recovery under high-pressure environments. It is an actively sought-after peptide raw material in the cognitive health and neurological function support sectors.
| CAS | 80714-61-0 |
| Molecular Formula | C₃₇H₅₁N₉O₁₁S |
| Molecular Weight | 813.92 g/mol |
| Category | Nootropic & Neuroprotective Peptides |
| Purity | >=99% (HPLC) |
| Status | Research-grade, analytical verified |
| Applications | Cognitive research, neuroprotection studies, BDNF modulation, stroke recovery |
| CAS | 80714-61-0 |
|---|---|
| Applications | BDNF modulation, Cognitive research, Neuroprotection studies, Stroke recovery |




